First publishedon www.AggBusiness.com
A new Memorandum of Understanding co-signed by EMBL and HeidelbergCement aims to encourage beneficial knowledge exchange in areas related to CO2 emission reduction, avoidance and recovery, as well as driving innovation.
“We are delighted to be partnering with EMBL, one of the world’s leading research institutions for molecular biology, to jointly explore innovative approaches to fight climate change,” explains Dr. Bernd Scheifele, chairman of the managing board of HeidelbergCement. “This will further strengthen our competence and our commitment to reduce the environmental footprint of our business.”
HeidelbergCement and EMBL will focus their collaborative activities on the coordination of conferences and workshops, bringing international experts to EMBL’s Advanced Training Centre to learn about and debate these important research areas. Meetings will also be initiated that bring together experts from both organisations to develop ideas, action plans and sustainable business practices. During the three-year period, HeidelbergCement and EMBL will also explore further areas for mutually beneficial collaborations.
“Climate change is an incredibly pressing issue,” says EMBL director, Prof. Matthias W. Hentze. “The science underpinning it is complex and we need the best scientists worldwide to put their heads together to look for innovative solutions. Building on our strong network of internationally leading scientists, EMBL will help facilitate this collaboration and promote discussion between experts.”
HeidelbergCement’s activities include the production and distribution of cement and aggregates, the two essential raw materials for concrete. With respect to volumes, concrete is the second most produced substance by mankind after drinking water. This is why almost 6% of all global CO2 emissions are coming from cement production. In order to reduce this environmental footprint, HeidelbergCement has already pledged to lower specific CO2 emissions by 30% by 2030 in comparison to 1990 levels.
EMBL is Europe’s flagship laboratory for the life sciences. It is an intergovernmental organisation established in 1974 and supported by over 20 member states. EMBL performs fundamental research in molecular biology, studying the story of life. It offers services to the scientific community, trains the next generation of scientists and strives to integrate the life sciences across Europe.